English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduHackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center successfully performed the first GammaTile® implant in the state. The device was implanted in a patient with recurrent meningioma, a brain tumor, to deliver radiation immediately at the time of surgery, targeting residual cancer cells to help prevent recurrence while minimizing harm to healthy tissue.
Tag: Radiation Oncolgy
MD Anderson Research Highlights: ASTRO 2023 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Rogel earns SPORE grant designed to further research on radiosensitization
An inter-departmental group of researchers at the University of Michigan Rogel Cancer Center received a grant from the National Cancer Institute to further research on radiosensitization, the process of making tumors more vulnerable to radiation treatment.
Women in Medicine: Dr. Priyamvada Rai to Co-lead Tumor Biology Research Program
Priyamvada Rai, Ph.D., is the new Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
Model helps predict which patients will benefit most from PSMA PET scan
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
Ronald Chen named a Fellow of the American Society for Radiation Oncology
Dr. Chen joins a group of just 19 physicians and medical physicists who are recognized this year for their contributions to the field of radiation oncology.
Schizophrenia drug combined with radiation shows promise in treating deadly brain tumors
UCLA researchers found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.